Human Albumin Ip | Klevolin

Klevolin Injection is a sterile preparation of Human Albumin IP, a plasma-derived protein solution used to restore and maintain adequate blood volume in patients suffering from fluid or protein loss. Albumin is the most abundant protein in human blood plasma and plays a vital role in maintaining oncotic pressure, which helps keep fluid within the blood vessels. Klevolin is commonly used in critical care settings for managing conditions such as Hypovolemia, Burns, and Liver Cirrhosis, where there is a significant loss of plasma proteins and fluids.

Human Albumin works by increasing the plasma volume, thereby improving blood circulation and ensuring adequate oxygen and nutrient delivery to vital organs. It also helps in stabilizing blood pressure and preventing complications associated with severe fluid loss. In patients with liver disorders such as cirrhosis, albumin levels are often low, leading to fluid accumulation in the abdomen (ascites). Administration of Klevolin helps correct this imbalance and improves overall clinical outcomes.

Klevolin Injection is also widely used in cases of shock, trauma, and major surgeries where rapid volume expansion is required. It is particularly beneficial in maintaining hemodynamic stability in critically ill patients. In addition, it may be used during dialysis procedures to prevent low blood pressure and support fluid balance. The infusion helps restore protein levels in the blood, which is essential for maintaining proper physiological function.

Another important use of Human Albumin is in the management of severe infections and conditions where there is a risk of fluid leakage from blood vessels into surrounding tissues. By maintaining oncotic pressure, albumin prevents excessive fluid loss and supports proper fluid distribution within the body. This makes Klevolin an essential component in intensive care treatment protocols.

Klevolin Injection is administered intravenously under strict medical supervision, and the dosage depends on the patient’s condition, body weight, and clinical requirements. Healthcare professionals carefully monitor vital signs, fluid balance, and albumin levels during administration to ensure safety and effectiveness.

Human Albumin Ip

While Klevolin is generally well tolerated, some patients may experience mild side effects such as fever, chills, nausea, or allergic reactions. In rare cases, serious reactions like breathing difficulty or changes in blood pressure may occur, requiring immediate medical attention. It is important to inform the healthcare provider about any known allergies or medical history before starting the treatment.

This injection is not recommended for individuals with severe anemia or heart failure without proper evaluation, as excessive fluid administration may worsen the condition. Careful monitoring is essential in patients with kidney or cardiac disorders.

In conclusion, Klevolin Injection is a life-saving formulation of Human Albumin IP that plays a crucial role in restoring blood volume, maintaining fluid balance, and supporting vital organ function. Its effectiveness in managing conditions like Hypovolemia and Liver Cirrhosis makes it an indispensable treatment in emergency and critical care settings. When administered under proper medical supervision, Klevolin helps improve patient outcomes and supports recovery in serious medical conditions.